Laminin (925-933): Precision Peptide for Cell Adhesion, Migration, and ECM Signaling Research

Executive Summary: Laminin (925-933) is a synthetic peptide mimicking residues 925-933 of the laminin B1 chain, designed for cell adhesion and migration studies (APExBIO). This peptide specifically binds the laminin receptor, facilitating cell attachment and chemotaxis in vitro. At 100–300 μg/mL, it stimulates HT-1080 and CHO cell attachment, and acts as a chemoattractant for B16F10 melanoma cells, achieving ~30% maximal response relative to full-length laminin. The peptide can competitively inhibit laminin-induced chemotaxis, highlighting its functional role in modulating cell migration (McGeachan et al., 2025). Laminin (925-933) is a robust tool for metastasis, extracellular matrix signaling, and neurobiology workflows.

Biological Rationale

Laminins are a family of extracellular matrix (ECM) glycoproteins essential for basement membrane structure and function. The B1 chain sequence, from which Laminin (925-933) is derived, is critical for cell-matrix interactions (McGeachan et al., 2025). These interactions govern cell adhesion, migration, differentiation, and tissue homeostasis. Disrupted ECM signaling is implicated in cancer metastasis and neurodegenerative disease (DOI). Cell adhesion peptides like Laminin (925-933) enable precise modeling of these processes in vitro, facilitating mechanistic studies and assay development.

Mechanism of Action of Laminin (925-933)

Laminin (925-933) is an eight-residue peptide (Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg) corresponding to residues 925–933 of the mouse laminin B1 chain. It binds specifically to the laminin cell surface receptor, mimicking a native cell attachment sequence. This binding initiates downstream signaling events that promote cell adhesion, migration, and chemotactic responses (APExBIO). The peptide can competitively inhibit full-length laminin in chemotaxis assays, indicating shared receptor engagement and functional relevance in modulating ECM-driven cell migration.

Evidence & Benchmarks

• Laminin (925-933) stimulates attachment of HT-1080 (human fibrosarcoma) and CHO (Chinese hamster ovary) cells to tissue culture plates at concentrations of 100–300 μg/mL (APExBIO, product page).
• Acts as a chemoattractant for B16F10 murine melanoma cells, eliciting ~30% of the maximal chemotactic response compared to full-length laminin (McGeachan et al., 2025).
• Competitively inhibits B16F10 chemotaxis toward full-length laminin, demonstrating functional receptor competition (APExBIO, product page).
• Stable as a solid at -20°C and soluble at ≥15.53 mg/mL in water, ≥17.77 mg/mL in ethanol, and ≥48.35 mg/mL in DMSO (APExBIO, product page).
• Used as an ECM signaling modulator in translational cancer and neurobiology research workflows (cadherin-peptide.com; see how this article extends mechanistic insights by integrating competitive inhibition data).
• Benchmarked by direct comparison to full-length laminin in cell migration and adhesion assays (cadherin-peptide.com; this article provides actionable protocols, while we focus on validated quantitative endpoints).

Applications, Limits & Misconceptions

Laminin (925-933) is validated for the following research applications:

• High-sensitivity cell adhesion and migration assays in cancer and neurobiology contexts.
• Competitive inhibition of ECM-induced chemotaxis for mechanistic dissection of signaling pathways.
• Screening of anti-metastatic compounds targeting laminin–receptor interactions.
• Modeling of basement membrane protein dynamics and receptor specificity.
• Translational studies on ECM signaling in neurodegeneration and metastasis (McGeachan et al., 2025).

Common Pitfalls or Misconceptions

• Not a diagnostic or therapeutic agent: Laminin (925-933) is strictly for research use and not for human or veterinary diagnostics or treatment (APExBIO).
• Limited to in vitro assays: Efficacy and specificity are established in controlled cell-based systems; in vivo utility has not been validated.
• Does not reproduce all full-length laminin functions: Only recapitulates receptor-binding and chemotactic properties, not higher-order ECM assembly.
• Concentration-dependent effects: Recommended range is 100–300 μg/mL; outside this may yield suboptimal or artifactual results.
• Short-term solution stability: Peptide solutions are recommended for immediate or short-term use due to potential degradation or aggregation.

Workflow Integration & Parameters

Laminin (925-933) (SKU A1023, APExBIO) is supplied as a solid, with a molecular weight of 967.06 Da. It is soluble in water (≥15.53 mg/mL), ethanol (≥17.77 mg/mL), and DMSO (≥48.35 mg/mL). The recommended storage is at -20°C; solutions should be freshly prepared for each experiment. For cell adhesion and chemotaxis assays, plate coating or solution-phase methods can be used, with validated concentrations of 100–300 μg/mL for cell attachment studies and migration assays. Protocols may be adapted based on cell line and assay format. For advanced troubleshooting and workflow optimization, see PeptideBridge (this resource focuses on protocol pain points, while our article delineates assay benchmarks and mechanistic limits).

Conclusion & Outlook

Laminin (925-933) is a robust, validated peptide for probing ECM-driven cell adhesion, migration, and signaling in vitro. Its competitive inhibition of full-length laminin establishes utility in dissecting receptor-ligand interactions and screening anti-metastatic strategies. As new insights into ECM signaling and neurodegeneration emerge (McGeachan et al., 2025), Laminin (925-933) provides a reproducible, high-sensitivity research tool for translational life science workflows. For detailed protocols, specifications, and ordering, refer to the Laminin (925-933) product page.